TABLE 2.
Patient Characteristics (N = 373)
| Age at implantation, y | 55 ± 14 |
| Sex | |
| Male | 293 (79) |
| Female | 80 (21) |
| Race | |
| Latino, Hispanic, or Spanish ethnicity | 43 (11) |
| White | 200 (54) |
| Black | 96 (26) |
| Asian | 16 (4) |
| American Indian/Alaska Native | 3 (1) |
| Other or unknown | 58 (15) |
| Comorbidities at implantation | |
| Diabetes | 134 (36) |
| Dyslipidemia | 195 (52) |
| Hypertension | 200 (54) |
| Chronic kidney disease | 146 (39) |
| Atrial arrhythmias | 180 (48) |
| Stroke | 39 (10) |
| Peripheral vascular disease | 26 (7) |
| Chronic obstructive pulmonary disease | 66 (18) |
| Payer | |
| Commercial | 124 (33) |
| Medicare | 162 (43) |
| Medicaid | 51 (14) |
| Other or unknown | 36 (10) |
| Marital status | |
| Unmarried or single | 94 (25) |
| Married or partnered | 230 (61) |
| Unknown | 49 (14) |
| HF etiology | |
| Nonischemic cardiomyopathy | 228 (61) |
| Ischemic cardiomyopathy | 145 (39) |
| LVAD type | |
| Heartmate II | 127 (34) |
| Heartware HVAD | 196 (53) |
| Heartmate III | 50 (13) |
| Implant strategy | |
| Bridge-to-transplantation | 182 (49) |
| Destination therapy | 191 (51) |
| INTERMACS profile | |
| 1 | 70 (19) |
| 2 | 137 (37) |
| 3 | 91 (24) |
| 4 | 27 (7) |
| 5–7 | 5 (1) |
| Unknown | 43 (12) |
| Reason for censor | |
| Transplantation | 155 (42) |
| End of study period | 111 (29) |
| Death | 77 (21) |
| Transfer of care | 23 (6) |
| Explantation | 7 (2) |
Values are mean ± SD or n (%).
HF = heart failure; INTERMACS = Interagency Registry for Mechanically Assisted Circulatory Support; LVAD = left ventricular assist device.